OVERVIEW

Insights on the 4th Young Investigators Forum in Lung Cancer is organized by prIME Oncology. This CME Conference has been approved for a maximum of 4.5 AMA PRA Category 1 Credit(s)™.

Target Audience:
The target audience for this activity includes medical oncologist junior faculty (MD or DO who has completed a fellowship within the past 5 years) and fellows (actively enrolled in a fellowship program) who are pursuing careers in lung cancer.

Learning Objectives:
After successful completion of this educational activity, participants should be able to:
• Assess the rationales, design, and endpoints in clinical trials investigating treatment options for lung cancer
• Select treatment for lung cancer based upon disease and patient characteristics
• Evaluate recent data from national society meetings that have the potential to impact practice including: immunotherapy, targeted therapies, sequencing, and combination therapy

Additional details will be posted as soon as they are available.